prolyl-phenylalanyl-arginine-4-methylcoumaryl-7-amide has been researched along with Libman-Sacks Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bangale, Y; Kalaga, R; Karle, S; Li, L; Nishiyama, Y; Paul, S; Planque, S; Taguchi, H; Zhou, YX | 1 |
| Caturegli, P; Dannenbring, RE; Hinrichs, S; Kalaga, R; Li, L; O'Dell, J; Paul, S; Rose, NR; Swindells, S | 1 |
2 other study(ies) available for prolyl-phenylalanyl-arginine-4-methylcoumaryl-7-amide and Libman-Sacks Disease
| Article | Year |
|---|---|
VIPase autoantibodies in Fas-defective mice and patients with autoimmune disease.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Catalysis; Cloning, Molecular; fas Receptor; Humans; Hydrolysis; Immunoglobulin Fragments; Immunoglobulin G; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Molecular Sequence Data; Mutation; Oligopeptides; Thyroglobulin; Thyroiditis, Autoimmune; Vasoactive Intestinal Peptide | 2003 |
Characterization of thyroglobulin-directed and polyreactive catalytic antibodies in autoimmune disease.
Topics: Autoantibodies; Binding Sites, Antibody; Catalysis; Fluorescent Dyes; Humans; Hydrolysis; Kinetics; Lupus Erythematosus, Systemic; Oligopeptides; Substrate Specificity; Thyroglobulin; Thyroiditis, Autoimmune | 1997 |